Oxidant/antioxidant status in patients with psoriasis

Yonsei Medical Journal

Volumn 44, Issue 6, 2003, Pages 987-990

  Baz, Kiymet ^a   Burak Cimen, M Y ^a   Kokturk, Aysin ^a   Yazici, Ayca Cordan ^a   Eskandari, Gulcin ^a   Ikizoglu, Guliz ^a   Api, Hale ^a   Atik, Ugur ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Antioxidant potential; Malondialdehyde; Plasma; Psoriasis; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PATHOGENESIS; PSORIASIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 0347756668     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.6.987     Document Type: Article

References (27)

1. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative stress and its role in skin disease. Antioxid Redox Signal 2002;4:665-73.
2. Maccarrone M, Catani MV, Iraci S, Melino G, Agro AF. A survey of reactive oxygen species and their role in dermatology. J Eur Acad Dermatol Venereol 1997;8:185-202.
3. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992;126:1-9.
4. Ortonne JP. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999;140: 1-7.
5. Popov I, Lewin G. A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 1991;35: 229-36.
6. Severin E, Nave B, Stander M, Ott R, Traupe H. Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels. Dermatology 1999;198:336-9.
7. Marks R, Barton SP, Shuttleworth D, Finlan AY. Assessment progress in psoriasis. Arch Dermatol 1989;125: 235-40.
8. Van Ye TM, Roza AM, Pieper GM, Henderson J Jr, Johnson CP, Adams MB. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J Surg Res 1993;55:553-8.
9. Durak I, Canbolat O, Kavutcu M, Öztürk HS, Yurtarslani Z. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996;10:17-20.
10. Özturk HS, Çimen MYB, Çimen ÖB, Kaçmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999; 19:35-7.
11. Miyachi Y, Niwa Y. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes. Arch Dermatol Res 1983; 275:23-6.
12. Turner CP, Toye AM, Jones OT. Keratinocyte superoxide generation. Free Radic Biol Med 1998;24:401-7.
13. Raynaud F, Evain-Brion D, Gerbaud P, Marciano D, Gorin I, Liapi C, et al. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radic Biol Med 1997;22: 623-32.
14. Correcher R, Ferrari S, De Gironcoli M, Bassi A, Olivieri O, Guarini P, et al. Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta 1989;179:121-32.
15. Kökçam I, Naziroǧlu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 1999;289:23-31.
16. Utaş S, Köse K, Yazici C, Akdaş A, Keleştimur F. Antioxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem 2002;35:241-6.
17. Kural BV, Örem A, Çimşit G, Yandi YE, Çalapoǧlu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003;328:71-82.
18. Drewa G, Krzyzynska-Malinowska E, Wozniak A, Protas-Drozd F, Mila-Kierzenkowska C, Rozwodowska M, et al. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med Sci Monit 2002;8:BR338-43.
19. Yildirim M, Inalöz HS, Baysal V, Delibaş N. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003;17:34-6.
20. Polkanov VS, Bochkarev IM, Shmeleva LT, Kipper SN. Lipid peroxidation and the blood antioxidant activity in psoriasis. Vestn Dermatol Venereol 1987;7:42-6.
21. Ivanova IP, Mareeva TE. Disorders of lipid peroxidation and of lysosomal hydrolase activity and their correction in psoriasis. Vestn Dermatol Venereol 1987;4: 26-31.
22. Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol 2002;29:399-403.
23. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quantanilha A, Teixeira F. Dyslipidemia and oxidative stress in mild and severe psoriasis as a risk for cardiovascular disease. Clin Chim. Acta 2001;303:33-9.
24. Kahler S, Christophers E, Schroder JM. Plasma lactoferrin reflects neutrophil activation in psoriasis. Br J Dermatol 1988;119:289-93.
25. Doǧan P, Soyuer U, Tanrikulu G. Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels in psoriasis. Br J Dermatol 1989;120:239-44.
26. Therond P, Gerbaud P, Dimon S, Anderson WB, Evain-Broin D, Raynaud F. Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J Invest Dermatol 1996;106:1325-8.
27. Gavan N, Popa R, Orasan R, Maibach H. Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis. Skin Pharmacol 1997;10:178-82.